The potential for endogenous or supplementary stem cells to restore the form and function of damaged tissues is particularly promising for overcoming the restricted regenerative capacity of the mammalian heart.
INTRODUCTION
trophy, leading to decompensated function and congestive heart failure.
Although cardiac regeneration has been presented as The mammalian heart must maintain its structural and functional integrity for decades, yet the response to an evolutionary variable (6) illustrated by the robust proliferative capacity of the injured heart in other vertebrate damage in this vital organ is remarkably inadequate and often results in heart failure, an increasingly prevalent such as newt and zebrafish (20, 21) , the mammalian heart is capable of homeostasis, occurring throughout cause of morbidity and mortality in the industrialized world. The impediments to cardiac repair have been at-life by cell renewal in the myocardium (18, 19) . However, the complete regenerative program in case of ex-tributed to the distinct embryonic history of the heart, which is the first fully differentiated structure to form tended injury is precluded in mammalian heart by fibrotic tissue formation and consequent cardiac func-and function in development. During fetal stages, actively contracting cardiomyocytes undergo rapid cell di-tional impairment. It is likely that the restricted cardiac repair program in mammals is presumably due to miss-vision to ensure further growth of the heart. This phase of proliferation ends soon after birth, when the capacity ing signals that render the damaged myocardium of lower vertebrates a permissive environment for regener-for cardiomyocytes to reenter the cell cycle appears to be largely lost, and increases in myocardial mass are ative activity. Given these limitations, strategies for repair of the achieved largely through cellular hypertrophy. In the adult, the relative rarity of progenitor cells residing damaged heart have followed two general approaches: injection or implantation of autologous or heterologous within the heart may impose severe limits on tissue repair. The injured heart needs a rapid response to repair regeneration-competent progenitor cells, or induction of endogenous regenerative mechanisms in the damaged damage to the muscle wall and maintain adequate blood flow to the rest of the body, but too often cannot restore myocardium. Although the first approach has been moderately successful at improving function through as yet the muscle loss that accompanies myocardial infarction and ischemia-reperfusion injury. Interruption of the cor-undetermined mechanisms (24) , it is increasingly clear that the appropriate tissue environment is critical for onary blood supply results in further cell death and fibrotic scar formation at the cost of functional muscle.
progenitor cells to be productively recruited and reconstitute injured tissue. Indeed, improving the tissue envi-Remaining cardiomyocytes respond by cellular hyper-ronment may broaden the scope of adult cell types that and plasmalemma and are rapidly activated in response to appropriate stimuli. Among these, IGF-1 has been im-can participate in functional restoration of the myocardium.
plicated in many anabolic pathways in skeletal muscle and plays a central role during muscle regeneration (26). One strategy to provide a regenerative environment in the damaged heart involves the use of insulin-like
We have previously documented the regenerative properties of a locally acting isoform, mIGF-1 in skeletal growth factor-1 (IGF-1), implicated in the control of cardiac growth in vitro and in vivo (9) . Injury of mamma-muscle and its dramatic promotion of cell survival and renewal in senescent muscle (16). Expressed as a mus-lian tissues induces transient production of locally acting IGF-1 isoforms that control growth, survival, and differ-cle-specific transgene or on a viral vector, mIGF-1 elicits a striking increase in skeletal muscle mass and entiation (10,26). By contrast, circulating IGF-1 isoforms have been implicated in the restriction of life span strength, a rapid restoration of injured muscle, reducing scar formation. Enhanced mobilization and homing of (1, 14) and have contrasting effects on the heart when expressed as transgenes, variously promoting cell sur-bone marrow-derived cells by local mIGF-1 is triggered by damage, and presumably contributes to increases in vival, or inducing prolonged hypertrophy with pathological consequences (7, 23) . The diverse forms of IGF-1 muscle mass, strength, and resistance in age-related atrophy and degenerative disease (17). are encoded in a single Igf-1 gene with complex structure and regulation, as well as posttranslational modifi-In mIGF-1 transgenic muscle, the dramatic increase in the bone marrow stem cell pool immediately after cations that remodel IGF-1 during protein biogenesis (26).
local muscle injury suggested a potential feedback mechanism whereby this rich source of stem cells is mo-LESSONS FROM SKELETAL MUSCLE bilized in response to distal trauma. After lethal irradiation of mIGF-1 mice to ablate native bone marrow, ex-The traditional paradigm of the heart as an organ incapable of regeneration has been put into question by ploitation of donor bone marrow carrying a GFP transgene driven by the c-kit promoter allowed the tracking of recent descriptions of a compartment of multipotent cardiac stem cells in the adult heart, capable of regenerating transplanted bone marrow-derived cells to skeletal muscle early in the regeneration process. The fourfold in-myocytes and coronary vessels throughout life (10). These studies provide a plausible explanation for the in-crease in GFP-positive cells migrating to the injured muscle of mIGF-1 transgenic mice compared to wild-herent self-renewing capacity of the adult organ in an unchallenged state, but major questions regarding car-type littermates suggests that local mIGF-1 induces the production of signals to increase the mobilization of un-diac physiology remain to be resolved. If cardiac muscle possesses a stem cell compartment it is not clear why committed cell subsets in the bone marrow, which migrate to sites of tissue damage and participate either di-the heart fails to regenerate under pathological conditions. Either the resident cardiac stem cells are too rare rectly or indirectly in the regeneration process. The enhancement of circulating cells drawn to regenerating or intrinsically incapable of repairing major damage, or perhaps the damaged myocardium is a prohibitive envi-mIGF-1 muscle tissue was not dependent upon lethal irradiation, as confirmed by the increase in c-kit/GFP+ ronment for activation. Although we lack definitive answers to the questions, we can speculate on the basis of cells after muscle injury of nonirradiated double transgenic mice. However, the dramatic increase in progeni-the processes involved in the regeneration of skeletal muscle that the mere presence of endogenous stem cells tor cells in mIGF-1 transgenic injured muscles was ablated by administration of 5-FU, a potent repressor of may not be sufficient to guarantee cardiac regeneration, and that the presence of appropriate stimuli and factors the cell cycle, which did not affect the abundance of nonproliferative cells at the site of injury. Thus, regener-is necessary to provide a permissive environment that allows stem cell-mediated cardiac regeneration and repair.
ative cell populations increased by the presence of mIGF-1 rely on proliferative capacity (16). The molecular mechanisms governing skeletal muscle regeneration are likely to be informative if not para-In primary cultures, mIGF-1 transgene expression expanded the myogenic population in response to muscle digmatic in the activation of cardiac regenerative processes. Skeletal muscle regeneration is a coordinate damage, containing 50% more myoblasts than did wildtype control cultures. When cocultured with bone mar-process in which several factors are sequentially activated to maintain and preserve muscle structure and row subpopulations that are not inherently myogenic, skeletal myoblasts isolated from mIGF-1 transgenic function upon injured stimuli.
The major role in the growth, remodeling, and regen-muscle stimulated the conversion of bone marrow cells to a myogenic lineage. In the skeletal muscle context, eration is played by satellite cells, a quiescent population of myogenic cells that reside between the basal lamina the mIGF-1 isoform is a powerful enhancer of local re-generation, mediating the recruitment of bone marrow replacement that restores form and function (M.P.S. and N.R., manuscript in preparation). cells to sites of tissue damage and their contribution to muscle repair (16). Taken together, these data emphasize
The origin and identity of cells that are stimulated by IGF-1 to promote cardiac regeneration is still under de-the importance of inductive signals, which increase the efficiency of stem cell action and improve tissue regen-bate. Some of these cells may correspond to a population of rare small cycling cardiomyocytes that retain the eration.
capacity to proliferate in response to damage (5, 8, 12) .
FROM SKELETAL TO CARDIAC MUSCLE
Cells capable of differentiating into a myocyte in the adult heart (15,22) could also originate through the com-Recent application of IGF-1 to the setting of myocardial infarction has demonstrated that this growth factor mitment of precursor cells to the myocyte lineage. Indeed, undifferentiated precursor cells in the adult heart can also contribute to an improved tissue environment in the damaged heart. Cardiac stem cells and early com-(2,11) have been identified through cell surface proteins that mark stem cell populations in other tissues. In some mitted cells express IGF-1 receptors and synthesize and secrete IGF-1 (25). When fully processed IGF-1 was in-cases these cells give rise to clones that express biochemical markers of myocytes, smooth muscle, and en-jected together with hepatocyte growth factor (HGF) into infarcted mouse hearts, this combination of growth dothelial cells in vitro, underscoring their stem cell-like nature. It is also possible that endothelial precursors are factors induced the formation of new myocardium that contained arterioles, capillaries, and functionally compe-stimulated by mIGF-1 to contribute directly to regenerating myocardial tissue. Indeed, adult human endothelial tent myocytes that gradually increased in size, improving ventricular performance. This improvement in myo-progenitor cells, derived from peripheral blood mononuclear cells, or hematopoietic progenitor cells can convert cardial regeneration was achieved through stimulation of an endogenous reserve of progenitor cells that can be into cardiomyocytes when cocultured with rat cardiomyocytes (3). In these studies, cell-cell contact or an extra-activated to reconstitute dead myocardium and recover cardiac function. This exciting study suggests that the cellular matrix-associated signaling appeared to be critical, because conditioned media from cardiocyte cultures heart can be transformed into a regeneration-competent organ through the combined actions of growth factors was not sufficient for conversion to a cardiomyocyte phenotype. Thus, it is possible that supplemental mIGF-that improve the local environment and activate endogenous stem cell reserves (25).
1 improves the tissue environment by reducing the fibrotic response through specific cell signaling pathways. To determine the extent to which supplemental expression of the mIGF-1 isoform on its own was capable Cycling myocardial cells induced by growth factor administration may also derive from recently character-of promoting regeneration of cardiac tissue, we generated transgenic mice in which the mIGF-1 transgene was ized cells isolated from the adult rat heart that retain stem cell characteristics (4) . These cells are self-renew-driven by a cardiac gene promoter, to restrict expression of mIGF-1 to the mouse myocardium and exclude possi-ing, clonogenic, and multipotent in vitro and in vivo and give rise to myocytes and smooth muscle and endothe-ble endocrine effects on other tissues. Transgenic mIGF-1 expression levels increased with age exclusively in the lial vascular cells. When injected into an ischemic rat heart, a population of these cells or their clonal progeny heart, which precociously attained adult size without perturbing function. In contrast to the characteristic pro-reconstitute up to 70% of the injured myocardial wall. This endogenous pool of primitive multipotent cells can gression of scar formation in wild-type hearts after myocardial infarction, mIGF-1 transgene expression induced be recruited into the regenerative process by the intramyocardial injection of a growth factor cocktail (IGF-1 repair of the injured tissue, with minimal scar formation after 1 month and integrity of the posterior wall and and HGF) to promote their translocation to the damaged area and activate their growth and differentiation, result-normal echocardiographic profiles. Functional parameters of the recovered mIGF-1 hearts were also signifi-ing in the formation of functionally competent myocardium. In this study, the blunted response to HGF or IGF-cantly improved when compared to infracted control animals. This functional improvement was due in part to 1 reported for alone has been attributed to the need for improvement of survival and promotion growth pro-an amelioration of the cellular environment of the postinfarct heart, with marked reduction in inflammatory vided by IGF-1 together with the chemotactic effects of HGF. However it is possible that fully processed IGF-1 markers and increased peri-infarct proliferative activity. These preliminary results suggest that in the mIGF-1 may not maintain the full spectrum of activities seen for the endogenous forms such as mIGF-1 (16). However, transgenic hearts, cardiac regeneration involves early resolution of inflammation at the site of injury to prevent the possibility that endogenous cardiac stem cells can be mobilized by growth factors to migrate from their niche scar formation, making way for the subsequent tissue within the healthy heart to support regeneration of dis-potential of resident cardiomyocytes. Although resident cardiac progenitor cell populations have now been iden-eased myocardium has exciting implications for therapeutic intervention (13).
tified, novel approaches are required to overcome the insufficiencies of endogenous stem cells to alleviate FUTURE PROSPECTS acute and chronic damage to mammalian cardiac tissue.
Because supplementary growth factors such as IGF-1 The repair of the mammalian heart is fast becoming a feasible goal of regenerative medicine. In the near fu-enhance myocardial regeneration following injury by enhancing endogenous repair mechanisms without af-ture, cardiac restoration is likely to be augmented through a number of avenues (Fig. 1) . The appropriate source of fecting long-term postnatal organ function, they may constitute clinically feasible therapeutic reagents to by-cells for these therapeutic applications is hotly debated, but the technical feasibility of using stem cell therapy to pass the normal restrictions on mammalian cardiac repair. Although the evidence to date for growth factor aid in replacement of cardiac tissues is well within realistic projections. Recent advances in our understanding supplementation is encouraging, it remains to be determined which IGF-1 isoforms or combination of growth have uncovered an unexpected dynamism in cardiac homeostasis and highlight the heterogeneous proliferative factors elicit the most effective response. These prelimi- Figure 1 . Modes of regeneration enhanced by mIGF-1. In the wake of a myocardial infarction, the action of IGF-1 stabilizes the necrotic zone and restricts fibrosis by activation of survival signals, secreting anti-inflammatory cytokines and chemoattractive molecules that promote contribution of progenitor cells to the areas of injury. In the top inset, endogenous precursor cell pools are activated to proliferate, and are recruited to the damage tissues. In the bottom inset, progenitor cell pools emanating from the bone marrow are attracted from the circulation to participate in the repair process. The precise identities of the cells in each scenario are not yet known, nor are the two scenarios seen to be mutually exclusive.
